HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Artisan iris-claw lenses for the correction of aphakia in children following lensectomy for ectopia lentis.

AbstractPURPOSE:
To describe the results of Artisan iris-claw lens implants in children with aphakia following lensectomy for ectopia lentis.
METHOD:
We measured visual acuity, refractive error and endothelial cell counts and recorded complications in a group of children after insertion of Artisan iris-claw implants.
RESULTS:
Artisan implants were implanted in eight eyes of five children. Mean follow-up was 28 months (range: 4-58 months). The mean preoperative LogMAR best-corrected visual acuity was 0.21 ± 0.2, and postoperatively, mean LogMAR uncorrected visual acuity was 0.04 ± 0.09 (p=0.04). Mean endothelial cell count was 3312 ± 277 cells preoperatively and 2913 ± 268 cells postoperatively, representing a mean cell loss of 14.2% (p<0.001). Mean defocus equivalent was 11.38 ± 1.04 preoperatively and 2.34 ± 0.66 postoperatively. We encountered no postoperative complications in any of the eyes.
CONCLUSION:
Artisan iris-claw implants are safe and effective in the correction of aphakia in children following lensectomy for ectopia lentis, enabling good spectacle-free distance vision in 75% of eyes with no postoperative complications.
AuthorsCatherine Cleary, Bernadette Lanigan, Michael O'Keeffe
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 96 Issue 3 Pg. 419-21 (Mar 2012) ISSN: 1468-2079 [Electronic] England
PMID21791507 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Aphakia, Postcataract (physiopathology, surgery)
  • Cell Count
  • Child
  • Child, Preschool
  • Ectopia Lentis (physiopathology, surgery)
  • Endothelium, Corneal (pathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Iris (surgery)
  • Lens Implantation, Intraocular
  • Lenses, Intraocular
  • Male
  • Treatment Outcome
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: